SKAN Group AGFRA:7VG +2.61%62 OCF Margin % is 20.90% as of Dec. 2025, which is 69% above its 10-year median of 12.37. GuruFocus rates FRA:7VG with a GF Score™ of 62/100 and a GF Value™ of €90.87 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 816 Medical Devices & Instruments companies, SKAN Group AG ranks better than 77.08% on this metric.
The historical rank and industry rank for SKAN Group AG's OCF Margin % or its related term are showing as below:
FRA:7VG'
s OCF Margin % Range Over the Past 10 Years
Min: 2.72 Med: 12.37 Max: 22.2
Current: 19.24
During the past 6 years, the highest OCF Margin % of SKAN Group AG was 22.20%. The lowest was 2.72%. And the median was 12.37%.
FRA:7VG's OCF Margin % is ranked better than 77.08% of 816
companies
in the Medical Devices & Instruments industry
Industry Median: 5.84
vs FRA:7VG: 19.24
SKAN Group AG OCF Margin % Related Terms
SKAN Group AG OCF Margin % Historical Data
* Premium members only.
The historical data trend for SKAN Group AG's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:7VG vs ISRG, BDX, MDLN: OCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, SKAN Group AG's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SKAN Group AG OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SKAN Group AG's OCF Margin % distribution charts can be found below:
* The bar in red indicates where SKAN Group AG's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SKAN Group AG (FRA:7VG) has a OCF Margin % of 20.90% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on SKAN Group AG and its competitors. This is 69% above median its historical median of 12.37. Over the past decade, SKAN Group AG's OCF Margin % has ranged from 2.72 to 22.20. According to the industry distribution chart, SKAN Group AG ranks #187 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 22.9%.
Is SKAN Group AG's OCF Margin % too high?
SKAN Group AG's current OCF Margin % of 20.90% is 69% above median its 10-year median of 12.37. Over the past 10 years, this metric has ranged from a low of 2.72 to a high of 22.20. The Medical Devices & Instruments industry median OCF Margin % is 5.84. SKAN Group AG's value of 20.90% is 257.9% above this industry median. Based on the distribution chart, SKAN Group AG ranks #187 out of 816 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, SKAN Group AG has a GF Score™ of 62/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does SKAN Group AG's OCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, SKAN Group AG ranks #187 out of 816 companies for OCF Margin %. This places SKAN Group AG in the top 23% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 5.84. SKAN Group AG's value of 20.90% is 257.9% above this benchmark. Historically, SKAN Group AG's own OCF Margin % has ranged from 2.72 to 22.20 over the past decade. While the company's 10-year median is 12.37 vs. the industry median of 5.84, SKAN Group AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.84, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SKAN Group AG's current OCF Margin % of 20.90% is 257.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on SKAN Group AG and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SKAN Group AG's current OCF Margin % is 20.90%, which is 69% above median its own 10-year median of 12.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SKAN Group AG stock overvalued right now?
Based on GuruFocus' analysis, SKAN Group AG (FRA:7VG) is currently considered Significantly Undervalued. The stock's GF Value™ is €90.87, compared to a current price of €59.00 — trading 35.1% below its estimated fair value. The current OCF Margin % is 20.90%, which is 69% above median its 10-year median of 12.37 and 257.9% above the Medical Devices & Instruments industry median of 5.84. SKAN Group AG's overall GF Score™ is 62/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For SKAN Group AG (FRA:7VG), the current OCF Margin % is 20.90% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SKAN Group AG (FRA:7VG) Overvalued in 2026?
Based on GuruFocus' analysis, SKAN Group AG stock appears to be undervalued.
The current stock price of €59.00 is trading 35.1% below its estimated GF Value™ of €90.87.
GuruFocus considers SKAN Group AG to be Significantly Undervalued.
Key valuation signals for FRA:7VG:
OCF Margin %: 20.90% (69% above median its 10-year median of 12.37)
GF Value™: €90.87 vs. price of €59.00 (35.1% below fair value)
Industry Position: 257.9% above the Medical Devices & Instruments median (#187 of 816)
No single metric tells the full story. See the FRA:7VG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SKAN Group AG is a market and technological company for isolators, cleanroom devices, and decontamination processes for the aseptic production of biopharmaceutical substances. The company offers its customers process support, services, and consumables. Its products include biological indicators, isolators, Laboratory/cleanroom equipment, laminar flow, safety workbenches, transfer systems, and others. The Firm has three operating segments: Equipment & solutions, Services & Consumables, and Other. The company generates the majority of its revenue from the Equipment & solutions segment. Geographically, the company derives revenue from Asia, Europe, Americas, and Other regions.
62GF Score
Get the complete analysis for FRA:7VG
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:7VG has been successfully added to your 
